Middle East and Africa Pharmaceutical Isolator Market Forecast to 2028 - COVID-19 Impact and Regional Analysis By Type (Open Isolator and Closed Isolator), Pressure (Positive Pressure and Negative Pressure), Configuration (Floor Standing, Modular, Mobile, and Compact), Application (Aseptic Isolators, Containment Isolators, Sampling and Weighing Isolators, Fluid Dispensing Isolators, and Others), and End User (Hospitals, Pharmaceutical and Biotechnology Companies, Research and Academic Laboratories, and Others)
Market Introduction
The MEA Pharmaceutical Isolator market is analyzed based on Saudi Arabia, UAE, South Africa, and the rest of MEA. In the current market scenario, the Middle East region is experiencing increasing pharmaceutical companies and manufacturing process. Saudi Arabia is leading the market. Saudi Arabia is one of the critical countries in the Middle Eastern region that has significant scope for biopharmaceutical contract manufacturing. The healthcare system in the country is developing at a rapid pace as well as an increasing number of sponsors are developing medical and research teams in the country. A sharp increase in the state health budget is also expected to create increasing demand for biopharmaceutical contract manufacturing in the country. Additionally, the country has a large number of clinical trials in progress. Moreover, Saudi Pharmaceutical Industries and Medical Appliances Corporation (SPIMACO), the listed Saudi Arabia-based company engaged in the production and marketing of medicines and medical appliances, has acquired a 48% stake in EirGen Pharma Limited, the Ireland-based pharmaceutical company, for a consideration of US$24 million. Saudi Pharmaceutical Industries & Medical Appliances Corporation (SPIMACO) has recently acquired an advanced integrated system for contamination control from Fedegari of Italy. Several players have expanded their business in the market by acquisitions, mergers, partnerships, and other strategic alliances. For instance, in May 2017, the latest manufacturing facility built by a Middle East partnership in King Abdullah Economic City, Jeddah. The project is the first Emirati-Saudi investment partnership in the pharmaceutical industry. This is helpful for drug discovery, and thus the healthcare policies favoring private sectors are expected to drive the growth of the pharmaceutical isolators market in the region.
In case of COVID-19, MEA is highly affected especially South Africa. The coronavirus pandemic has become the largest challenge to this region, as they are low-cost regions. For instance, due to the high uncertainty of the spread of COVID-19, the impact on Africa is expected to be severe, given the continent’s exposure to China. These regions are widely dependent on the import of pharmaceutical and biopharmaceutical equipment. The lockdown situation in many countries has resulted in no trade in foreign countries. Thus, the countries in the MEA have started producing API in their domestic market. However, the cost of production was a challenge for several countries. The Saudi government policies are favored of domestic pharmaceutical manufacturers including not any import duties on raw materials & intermediate products and interest-free funding support the growth of the pharmaceutical market in this region. Similarly, increasing incidence of COVID-19 create huge demand for aseptic processing of pharmaceutical products. This scenario is expected to offer several growth opportunities for pharmaceutical isolator market. In South Africa, adoption of aseptic processing during pandemic has significantly witnessed high growth, which is expected to increase the demand for pharmaceutical isolator market. For instance, Esco Technologies Pty Ltd has offered Esco Class II Biological Safety Cabinets to various laboratories and testing facilities in South Africa. Biosafety cabinets pose great importance in handling biohazards in COVID-19 testing facilities. All these factors will positively impact the pharmaceutical isolator market.
Get more information on this report :
Market Overview and Dynamics
The MEA pharmaceutical isolator market is expected to grow from US$ 258.00 million in 2021 to US$ 426.54 million by 2028; it is estimated to grow at a CAGR of 7.4% from 2021 to 2028. A pharmaceutical isolator offers a superior sterile environment than conventional clean rooms. Positive or negative pressures inside the chamber prevent contamination due to operator interference. It ensures long-lasting sterility in accordance with pharmaceutical regulations related to the manufacturing of sterile medicine products. Moreover, most of the experts agree that regulatory agencies are no longer impeding progress when it comes to technologies such as pharmaceutical isolators. The guidelines set by the agencies have an important role in the adoption of isolators in comparison to cleanrooms. Administration mentions isolators 55 times in its latest guideline of manufacturing in an aseptic environment. A well-designed positive pressure isolator, supported by adequate procedures for its maintenance, monitoring, and controls, offers significant advantages over traditional aseptic processing, including fewer opportunities for microbial contamination during processing. Isolators have become a core component of the pharmaceutical industry, as the cost of noncompliance with the regulatory guidelines is much high. Pharmaceutical isolators are critical for a range of processes to ensure aseptic conditions and containment. Stringent aseptic conditions are essential to maintain quality control and meet the administration current good manufacturing practice guidelines and other regulatory demands. WHO good manufacturing practices guidelines for sterile pharmaceutical products, section 8 of Annex 6 also mention the use of isolator technology to minimize human interventions in processing areas. All these regulatory guidelines fuel the adoption of pharmaceutical isolators in the MEA market.
Key Market Segments
In terms of type, the open isolator segment accounted for the largest share of the MEA pharmaceutical isolator market in 2020. In terms of pressure, the positive pressure segment held a larger market share of the MEA pharmaceutical isolator market in 2020. In terms of configuration, the floor standing segment held a larger market share of the MEA pharmaceutical isolator market in 2020. In terms of application, the aseptic isolators segment held a larger market share of the MEA pharmaceutical isolator market in 2020. Further, the pharmaceutical and biotechnology companies segment held a larger share of the MEA pharmaceutical isolator market based on end user in 2020.
Major Sources and Companies Listed
A few major primary and secondary sources referred to for preparing this report on the MEA pharmaceutical isolator market are company websites, annual reports, financial reports, national government documents, and statistical database, among others. Major companies listed in the report are Azbil Telstar, Bioquell (Ecolab Solution), Comecer, Fedegari Autoclavi S.p.A., Getinge AB, Hosokawa Micron Group, and Nuaire Inc.
Reasons to buy report
- To understand the MEA pharmaceutical isolator market landscape and identify market segments that are most likely to guarantee a strong return
- Stay ahead of the race by comprehending the ever-changing competitive landscape for MEA pharmaceutical isolator market
- Efficiently plan M&A and partnership deals in MEA pharmaceutical isolator market by identifying market segments with the most promising probable sales
- Helps to take knowledgeable business decisions from perceptive and comprehensive analysis of market performance of various segment form MEA pharmaceutical isolator market
- Obtain market revenue forecast for market by various segments from 2021-2028 in MEA region.
MEA Pharmaceutical Isolator Market Segmentation
MEA Pharmaceutical Isolator Market - By Type
- Open Isolators
- Closed Isolators
MEA Pharmaceutical Isolator Market - By Pressure
- Positive Pressure
- Negative Pressure
MEA Pharmaceutical Isolator Market - By Configuration
- Floor Standing
- Modular
- Compact
- Mobile
MEA Pharmaceutical Isolator Market - By Application
- Aseptic
- Sampling & Weighing
- Fluid Dispensing
- Containment
- Others
MEA Pharmaceutical Isolator Market – By End User
- Pharmaceutical and Biotechnology Companies
- Hospitals
- Research and Academic Laboratories
- Other
MEA Pharmaceutical Isolator Market - By Country
- Saudi Arabia
- UAE
- South Africa
- Rest of MEA
MEA Pharmaceutical Isolator Market - Company Profiles
- Azbil Telstar
- Bioquell (Ecolab Solution)
- Comecer
- Fedegari Autoclavi S.p.A.
- Getinge AB
- Hosokawa Micron Group
- Nuaire Inc.
TABLE OF CONTENTS
1. Introduction
1.1 Scope of the Study
1.2 The Insight Partners Research Report Guidance
1.3 Market Segmentation
1.3.1 MEA Pharmaceutical Isolator Market – By Type
1.3.2 MEA Pharmaceutical Isolator Market – By Pressure
1.3.3 MEA Pharmaceutical Isolator Market – By Configuration
1.3.4 MEA Pharmaceutical Isolator Market – By Application
1.3.5 MEA Pharmaceutical Isolator Market – By End User
1.3.6 MEA Pharmaceutical Isolator Market – By Country
2. Key Takeaways
3. Research Methodology
3.1 Coverage
3.2 Secondary Research
3.3 Primary Research
4. Market Landscape
4.1 Overview
4.2 MEA PEST Analysis
4.3 Experts Opinion
5. MEA Pharmaceutical Isolator Market – Key Market Dynamics
5.1 Market Drivers
5.1.1 Escalating Investments by Pharmaceutical and Biotechnology Industry
5.1.2 System to Support Adoption of Pharmaceutical Isolators
5.2 Market Restraint
5.2.1 Expensive Operation and Maintenance
5.3 Market Opportunities
5.3.1 Burgeoning Pharmaceutical and Biotechnological Industries
5.4 Future Trends
5.4.1 Surging Adoption of Automation in Pharmaceutical Isolator
5.5 Impact Analysis
6. Pharmaceutical Isolator Market – MEA Analysis
6.1 MEA Pharmaceutical Isolator Market Revenue Forecast and Analysis
7. MEA Pharmaceutical Isolator Market Analysis and forecasts to 2028 –By Type
7.1 Overview
7.2 MEA Pharmaceutical Isolator Market Share by Type 2021 & 2028 (%)
7.3 Open Isolator
7.3.1 Overview
7.3.2 Open Isolator Market Revenue and Forecast to 2028 (US$ Mn)
7.4 Closed Isolator
7.4.1 Overview
7.4.2 Closed Isolator Market Revenue and Forecast to 2028 (US$ Mn)
8. MEA Pharmaceutical Isolator Market Analysis and Forecasts to 2028 –By Pressure
8.1 Overview
8.2 MEA Pharmaceutical Isolator Market Share by Pressure 2021 & 2028 (%)
8.3 Positive Pressure
8.3.1 Overview
8.3.2 Positive Pressure Market Revenue and Forecast to 2028 (US$ Mn)
8.4 Negative Pressure
8.4.1 Overview
8.4.2 Negative Pressure Market Revenue and Forecast to 2028 (US$ Mn)
9. MEA Pharmaceutical Isolator Market Analysis and Forecasts to 2028 –By Configuration
9.1 Overview
9.2 MEA Pharmaceutical Isolator Market Share by Configuration 2021 & 2028 (%)
9.3 Floor Standing
9.3.1 Overview
9.3.2 Floor Standing Market Revenue and Forecast to 2028 (US$ Mn)
9.4 Modular
9.4.1 Overview
9.4.2 Modular Market Revenue and Forecast to 2028 (US$ Mn)
9.5 Compact
9.5.1 Overview
9.5.2 Compact Market Revenue and Forecast to 2028 (US$ Mn)
9.6 Mobile
9.6.1 Overview
9.6.2 Mobile Market Revenue and Forecast to 2028 (US$ Mn)
10. MEA Pharmaceutical Isolator Market Analysis and Forecasts to 2028 –By Application
10.1 Overview
10.2 MEA Pharmaceutical Isolator Market Share by Application 2021 & 2028 (%)
10.3 Aseptic Isolators
10.3.1 Overview
10.3.2 Aseptic Isolators Market Revenue and Forecast to 2028 (US$ Mn)
10.4 Sampling and Weighing Isolators
10.4.1 Overview
10.4.2 Sampling and Weighing Isolators Market Revenue and Forecast to 2028 (US$ Mn)
10.5 Fluid Dispensing Isolators
10.5.1 Overview
10.5.2 Fluid Dispensing Isolators Market Revenue and Forecast to 2028 (US$ Mn)
10.6 Containment Isolators
10.6.1 Overview
10.6.2 Containment Isolators Market Revenue and Forecast to 2028 (US$ Mn)
10.7 Others
10.7.1 Overview
10.7.2 Others Market Revenue and Forecast to 2028 (US$ Mn)
11. MEA Pharmaceutical Isolator Market Analysis and Forecasts to 2028 –By End User
11.1 Overview
11.2 MEA Pharmaceutical Isolator Market Share by End User 2021 & 2028 (%)
11.3 Pharmaceuticals and Biotechnology Companies
11.3.1 Overview
11.3.2 Pharmaceutical And Biotechnology Market Revenue and Forecast to 2028 (US$ Mn)
11.4 Hospitals
11.4.1 Overview
11.4.2 Hospitals Market Revenue and Forecast to 2028 (US$ Mn)
11.5 Research and Academic Laboratories
11.5.1 Overview
11.5.2 Research and Academic Laboratories Market Revenue and Forecast to 2028 (US$ Mn)
11.6 Others
11.6.1 Overview
11.6.2 Others Market Revenue and Forecast to 2028 (US$ Mn)
12. MEA Pharmaceutical Isolator Market – Country Analysis
12.1 MEA: Pharmaceutical Isolator Market
12.1.1 Overview
12.1.2 MEA: Pharmaceutical Isolator Market, by Country, 2021 & 2028 (%)
12.1.2.1 Saudi Arabia: Pharmaceutical Isolator Market – Revenue and Forecast to 2028 (US$ Million)
12.1.2.1.1 Saudi Arabia: Pharmaceutical Isolator Market – Revenue and Forecast to 2028 (US$ Million)
12.1.2.1.2 Saudi Arabia Pharmaceutical Isolator Market , by Type– Revenue and Forecast to 2028 (USD Million)
12.1.2.1.3 Saudi Arabia Pharmaceutical Isolator Market , by Pressure– Revenue and Forecast to 2028 (USD Million)
12.1.2.1.4 Saudi Arabia Pharmaceutical Isolator Market , by Configuration– Revenue and Forecast to 2028 (USD Million)
12.1.2.1.5 Saudi Arabia Pharmaceutical Isolator Market , by Application– Revenue and Forecast to 2028 (USD Million)
12.1.2.1.6 Saudi Arabia Pharmaceutical Isolator Market , by End User– Revenue and Forecast to 2028 (USD Million)
12.1.2.2 UAE: Pharmaceutical Isolator Market – Revenue and Forecast to 2028 (US$ Million)
12.1.2.2.1 UAE: Pharmaceutical Isolator Market – Revenue and Forecast to 2028 (US$ Million)
12.1.2.2.2 UAE: Pharmaceutical Isolator Market – Revenue and Forecast to 2028 (US$ Million)
12.1.2.2.3 UAE Pharmaceutical Isolator Market , by Type– Revenue and Forecast to 2028 (USD Million)
12.1.2.2.4 UAE Pharmaceutical Isolator Market , by Pressure– Revenue and Forecast to 2028 (USD Million)
12.1.2.2.5 UAE Pharmaceutical Isolator Market , by Configuration– Revenue and Forecast to 2028 (USD Million)
12.1.2.2.6 UAE Pharmaceutical Isolator Market , by Application– Revenue and Forecast to 2028 (USD Million)
12.1.2.2.7 UAE Pharmaceutical Isolator Market , by End User– Revenue and Forecast to 2028 (USD Million)
12.1.2.3 South Africa: Pharmaceutical Isolator Market – Revenue and Forecast to 2028 (US$ Million)
12.1.2.3.1 South Africa: Pharmaceutical Isolator Market – Revenue and Forecast to 2028 (US$ Million)
12.1.2.3.2 South Africa Pharmaceutical Isolator Market , by Type– Revenue and Forecast to 2028 (USD Million)
12.1.2.3.3 South Africa Pharmaceutical Isolator Market , by Pressure– Revenue and Forecast to 2028 (USD Million)
12.1.2.3.4 South Africa Pharmaceutical Isolator Market , by Configuration– Revenue and Forecast to 2028 (USD Million)
12.1.2.3.5 South Africa Pharmaceutical Isolator Market , by Application– Revenue and Forecast to 2028 (USD Million)
12.1.2.3.6 South Africa Pharmaceutical Isolator Market , by End User– Revenue and Forecast to 2028 (USD Million)
12.1.2.4 Rest of MEA: Pharmaceutical Isolator Market – Revenue and Forecast to 2028 (US$ Million)
12.1.2.4.1 Rest of MEA: Pharmaceutical Isolator Market – Revenue and Forecast to 2028 (US$ Million)
12.1.2.4.2 Rest of MEA Pharmaceutical Isolator Market , by Type– Revenue and Forecast to 2028 (USD Million)
12.1.2.4.3 Rest of MEA Pharmaceutical Isolator Market , by Pressure– Revenue and Forecast to 2028 (USD Million)
12.1.2.4.4 Rest of MEA Pharmaceutical Isolator Market , by Configuration– Revenue and Forecast to 2028 (USD Million)
12.1.2.4.5 Rest of MEA Pharmaceutical Isolator Market , by Application– Revenue and Forecast to 2028 (USD Million)
12.1.2.4.6 Rest of MEA Pharmaceutical Isolator Market , by End User– Revenue and Forecast to 2028 (USD Million)
13. Impact of COVID-19 Pandemic on MEA Pharmaceutical Isolator Market
13.1 MEA: Impact Assessment of COVID-19 Pandemic
14. Industry Landscape
14.1 Overview
14.2 Organic Developments
14.2.1 Overview
14.3 Inorganic Developments
14.3.1 Overview
15. Company Profiles
15.1 Nuaire Inc.
15.1.1 Key Facts
15.1.2 Business Description
15.1.3 Products and Services
15.1.4 Financial Overview
15.1.5 SWOT Analysis
15.1.6 Key Developments
15.2 Comecer
15.2.1 Key Facts
15.2.2 Business Description
15.2.3 Products and Services
15.2.4 Financial Overview
15.2.5 SWOT Analysis
15.2.6 Key Developments
15.3 Getinge AB
15.3.1 Key Facts
15.3.2 Business Description
15.3.3 Products and Services
15.3.4 Financial Overview
15.3.5 SWOT Analysis
15.3.6 Key Developments
15.4 Hosokawa Micron Group
15.4.1 Key Facts
15.4.2 Business Description
15.4.3 Products and Services
15.4.4 Financial Overview
15.4.5 SWOT Analysis
15.4.6 Key Developments
15.5 Fedegari Autoclavi S.p.A.
15.5.1 Key Facts
15.5.2 Business Description
15.5.3 Products and Services
15.5.4 Financial Overview
15.5.5 SWOT Analysis
15.5.6 Key Developments
15.6 Azbil Telstar
15.6.1 Key Facts
15.6.2 Business Description
15.6.3 Products and Services
15.6.4 Financial Overview
15.6.5 SWOT Analysis
15.6.6 Key Developments
15.7 Bioquell ( Ecolab Solution)
15.7.1 Key Facts
15.7.2 Business Description
15.7.3 Products and Services
15.7.4 Financial Overview
15.7.5 SWOT Analysis
15.7.6 Key Developments
16. Appendix
16.1 About The Insight Partners
16.2 Glossary of Terms
LIST OF TABLES
Table 1. MEA Pharmaceutical Isolator Market – Revenue and Forecast to 2028 (USD Million)
Table 2. Saudi Arabia Pharmaceutical Isolator Market , by Type – Revenue and Forecast to 2028 (USD Million)
Table 3. Saudi Arabia Pharmaceutical Isolator Market , by pressure – Revenue and Forecast to 2028 (USD Million)
Table 4. Saudi Arabia Pharmaceutical Isolator Market , by Configuration – Revenue and Forecast to 2028 (USD Million)
Table 5. Saudi Arabia Pharmaceutical Isolator Market , by Application– Revenue and Forecast to 2028 (USD Million)
Table 6. Saudi Arabia Pharmaceutical Isolator Market , by End User – Revenue and Forecast to 2028 (USD Million)
Table 7. UAE Pharmaceutical Isolator Market , by Type – Revenue and Forecast to 2028 (USD Million)
Table 8. UAE Pharmaceutical Isolator Market , by Pressure – Revenue and Forecast to 2028 (USD Million)
Table 9. UAE Pharmaceutical Isolator Market , by Configuration – Revenue and Forecast to 2028 (USD Million)
Table 10. UAE Pharmaceutical Isolator Market , by Application– Revenue and Forecast to 2028 (USD Million)
Table 11. UAE Pharmaceutical Isolator Market , by End User – Revenue and Forecast to 2028 (USD Million)
Table 12. South Africa Pharmaceutical Isolator Market , by Type – Revenue and Forecast to 2028 (USD Million)
Table 13. South Africa Pharmaceutical Isolator Market , by Pressure – Revenue and Forecast to 2028 (USD Million)
Table 14. South Africa Pharmaceutical Isolator Market , by Configuration – Revenue and Forecast to 2028 (USD Million)
Table 15. South Africa Pharmaceutical Isolator Market , by Application– Revenue and Forecast to 2028 (USD Million)
Table 16. South Africa Pharmaceutical Isolator Market , by End User– Revenue and Forecast to 2028 (USD Million)
Table 17. Rest of MEA Pharmaceutical Isolator Market , by Type – Revenue and Forecast to 2028 (USD Million)
Table 18. Rest of MEA Pharmaceutical Isolator Market , by Pressure – Revenue and Forecast to 2028 (USD Million)
Table 19. Rest of MEA Pharmaceutical Isolator Market , by Configuration – Revenue and Forecast to 2028 (USD Million)
Table 20. Rest of MEA Pharmaceutical Isolator Market , by Application– Revenue and Forecast to 2028 (USD Million)
Table 21. Rest of MEA Pharmaceutical Isolator Market , by End User– Revenue and Forecast to 2028 (USD Million)
Table 22. Organic Developments Done By Companies
Table 23. Inorganic Developments Done by Companies
Table 24. Glossary of Terms
LIST OF FIGURES
Figure 1. MEA Pharmaceutical Isolator Market Segmentation
Figure 2. MEA Pharmaceutical Isolator Market Segmentation, By Country
Figure 3. MEA Pharmaceutical Isolator Market Overview
Figure 4. Open Isolators Segment led the Market in 2021
Figure 5. Saudi Arabia to Show Significant Growth During Forecast Period
Figure 6. MEA PEST Analysis
Figure 7. MEA Pharmaceutical Isolator Market Impact Analysis of Driver and Restraints
Figure 8. MEA Pharmaceutical Isolator Market – Revenue Forecast and Analysis
Figure 9. MEA Pharmaceutical Isolator Market Share by Type 2021 & 2028 (%)
Figure 10. MEA Open Isolator Market Revenue and Forecasts to 2028 (US$ Mn)
Figure 11. MEA Closed Isolator Market Revenue and Forecasts to 2028 (US$ Mn)
Figure 12. MEA Pharmaceutical Isolator Market Share by Pressure 2021 & 2028 (%)
Figure 13. MEA Positive Pressure Market Revenue and Forecasts to 2028 (US$ Mn)
Figure 14. MEA Negative Pressure Market Revenue and Forecasts to 2028 (US$ Mn)
Figure 15. MEA Pharmaceutical Isolator Market Share by Configuration 2021 & 2028 (%)
Figure 16. MEA Floor Standing Market Revenue and Forecasts to 2028 (US$ Mn)
Figure 17. MEA Modular Market Revenue and Forecasts to 2028 (US$ Mn)
Figure 18. MEA Compact Market Revenue and Forecasts to 2028 (US$ Mn)
Figure 19. MEA Mobile Market Revenue and Forecasts to 2028 (US$ Mn)
Figure 20. MEA Pharmaceutical Isolator Market Share by Application 2021 & 2028 (%)
Figure 21. MEA Aseptic Isolators Market Revenue and Forecasts to 2028 (US$ Mn)
Figure 22. MEA Sampling and Weighing Isolators Market Revenue and Forecasts to 2028 (US$ Mn)
Figure 23. MEA Fluid Dispensing Isolators Market Revenue and Forecasts to 2028 (US$ Mn)
Figure 24. MEA Containment Isolators Market Revenue and Forecasts to 2028 (US$ Mn)
Figure 25. MEA Others Market Revenue and Forecasts to 2028 (US$ Mn)
Figure 26. MEA Pharmaceutical Isolator Market Share by End User 2021 & 2028 (%)
Figure 27. MEA Pharmaceutical And Biotechnology Market Revenue and Forecasts to 2028 (US$ Mn)
Figure 28. MEA Hospitals Market Revenue and Forecasts to 2028 (US$ Mn)
Figure 29. MEA Research and Academic Laboratories Market Revenue and Forecasts to 2028 (US$ Mn)
Figure 30. MEA Others Market Revenue and Forecasts to 2028 (US$ Mn)
Figure 31. MEA: Pharmaceutical Isolator Market, by Key Country – Revenue (2021) (USD Million)
Figure 32. MEA: Pharmaceutical Isolator Market, by Country, 2021 & 2028 (%)
Figure 33. Saudi Arabia: Pharmaceutical Isolator Market – Revenue and Forecast to 2028 (US$ Million)
Figure 34. UAE: Pharmaceutical Isolator Market – Revenue and Forecast to 2028 (US$ Million)
Figure 35. South Africa: Pharmaceutical Isolator Market – Revenue and Forecast to 2028 (US$ Million)
Figure 36. Rest of MEA: Pharmaceutical Isolator Market – Revenue and Forecast to 2028 (US$ Million)
Figure 37. Impact Of COVID-19 Pandemic MEA Market
- Azbil Telstar
- Bioquell (Ecolab Solution)
- Comecer
- Fedegari Autoclavi S.p.A.
- Getinge AB
- Hosokawa Micron Group
- Nuaire Inc.
- Save and reduce time carrying out entry-level research by identifying the growth, size, leading players, and segments in the MEA pharmaceutical isolator market.
- Highlights key business priorities in order to assist companies to realign their business strategies
- The key findings and recommendations highlight crucial progressive industry trends in MEA pharmaceutical isolator market, thereby allowing players across the value chain to develop effective long-term strategies
- Develop/modify business expansion plans by using substantial growth offering developed and emerging markets
- Scrutinize in-depth MEA market trends and outlook coupled with the factors driving the pharmaceutical isolator market, as well as those hindering it
- Enhance the decision-making process by understanding the strategies that underpin commercial interest with respect to client products, segmentation, pricing, and distribution